Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 8Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 51Other hematologic neoplasm 25Sarcoma 3Myeloid 3Classical hematology 3Plasma cell 2Dermatologic 2Thoracic 1Other neoplasm 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 173Head and Neck Neoplasms 141Thyroid Neoplasms 59Carcinoma, Non-Small-Cell Lung 58Oropharyngeal Neoplasms 48Melanoma 47Nasopharyngeal Carcinoma 45Colorectal Neoplasms 33Mouth Neoplasms 30Carcinoma, Renal Cell 29Breast Neoplasms 27Uterine Cervical Neoplasms 26Neoplasms 26Ovarian Neoplasms 25Stomach Neoplasms 24Carcinoma, Squamous Cell 23Lung Neoplasms 22Esophageal Neoplasms 22Triple Negative Breast Neoplasms 20Neoplasm Metastasis 20Endometrial Neoplasms 20Salivary Gland Neoplasms 19Thyroid Cancer, Papillary 16Pancreatic Neoplasms 16Sarcoma 15Laryngeal Neoplasms 15Urinary Bladder Neoplasms 13Prostatic Neoplasms 13Colonic Neoplasms 13Carcinoma, Transitional Cell 13

Interventions

HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Burkitt Lymphoma × Head & Neck × Clear all
NCT05565417 2025-10-16

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Immunitas Therapeutics

Phase 1/2 Active not recruiting
67 enrolled
BreastGastrointestinalHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡